ALHC (Alignment Healthcare) Growth Rank: 10 (As of Aug. 02, 2026) — 11% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALHC Alignment Healthcare Inc ALHC
79 GF Score
Price $14.84
GF Value $20.32
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alignment Healthcare Growth Rank?

Alignment Healthcare ALHC -20.20% 79 Growth Rank is 10 as of Aug. 02, 2026, which is 11% above its 10-year median of 9.00. GuruFocus rates ALHC with a GF Score™ of 79/100 and a GF Value™ of $20.32 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Alignment Healthcare has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Alignment Healthcare Growth Rank Related Terms

ALHC vs PGNY, CLOV, PFHO: Growth Rank Comparison

For the Healthcare Plans subindustry, Alignment Healthcare's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alignment Healthcare Growth Rank vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's Growth Rank distribution charts can be found below:

* The bar in red indicates where Alignment Healthcare's Growth Rank falls into.


ALHC
79GF Score
Alignment Healthcare Inc ALHC
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Alignment Healthcare (ALHC) has a Growth Rank of 10 as of Aug. 02, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Alignment Healthcare and its competitors. This is 11% above median its historical median of 9.00. Over the past decade, Alignment Healthcare's Growth Rank has ranged from 9.00 to 10.00.
Is Alignment Healthcare's Growth Rank too high?
Alignment Healthcare's current Growth Rank of 10 is 11% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 9.00 to a high of 10.00. Overall, Alignment Healthcare has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alignment Healthcare's Growth Rank compare to PGNY and CLOV?
Alignment Healthcare's Growth Rank of 10 can be compared against companies in the Healthcare Plans industry. Historically, Alignment Healthcare's own Growth Rank has ranged from 9.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Plans company?
A good Growth Rank depends on the Healthcare Plans industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Alignment Healthcare and its competitors. Alignment Healthcare's current Growth Rank is 10, which is 11% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alignment Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Alignment Healthcare (ALHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.32, compared to a current price of $14.84 — trading 27% below its estimated fair value. The current Growth Rank is 10, which is 11% above median its 10-year median of 9.00. Alignment Healthcare's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Alignment Healthcare (ALHC), the current Growth Rank is 10 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alignment Healthcare (ALHC) Overvalued in 2026?

Based on GuruFocus' analysis, Alignment Healthcare stock appears to be undervalued. The current stock price of $14.84 is trading 27% below its estimated GF Value™ of $20.32. GuruFocus considers Alignment Healthcare to be Modestly Undervalued.

Key valuation signals for ALHC:

  • Growth Rank: 10 (11% above median its 10-year median of 9.00)
  • GF Value™: $20.32 vs. price of $14.84 (27% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the ALHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alignment Healthcare Business Description

Address 1100 W. Town and Country Road, Suite 1600, Orange, CA, USA, 92868
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
79GF Score

Get the complete analysis for ALHC

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.84
Price
$20.32
GF Value